MedPath

EVENITY

EVENITY

Approved
DIN Number

02489597

Drug Class

Human

Market Date

Aug 12, 2019

Company
HC

Amgen Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02489597
AIG Number0161530001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
M05BX06 ROMOSOZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:16.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ROMOSOZUMABActive
Strength: 105 MG / 1.17 ML
Monograph: ROMOSOZUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.